“THE KOL MEETING FOR KOL’S”
DAVIS, Calif., June 6, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a science-based, data-driven regenerative aesthetic skincare company is pleased to announce that Co-Founder and CEO Dr. Jordan Plews has been selected to speak at the world-renowned Beauty Through Sciences Symposium as a Stem Cell Exosome Key Opinion Leader (KOL).
About the Beauty Through Science (BTS) Congress
The BTS Congress (Beauty Through Science) is one of the largest aesthetic medicine symposiums in Europe. The Beauty Through Science 2022 Congress is held June 8-11 in Stockholm, Sweden. BTS is a boutique meeting, covering both surgical and non-surgical aesthetics. Esteemed KOL speakers come from all over the world to share the latest insights and advancements. For more information and sign up visit: https://www.beautythroughscience.com/bts-stockholm-home
Dr. Jordan Plews stated: “Innovation in Stem Cell Exosome Research has come a long way in the last 5-10 years. I’m honored to be invited to speak at this year’s BTS Congress on the science and the opportunity for human stem cell derived exosomes in regenerative skin care applications. I look forward to meeting many other talented scientists and medical aesthetic professionals that share a passion for next generation regenerative technologies.”
About ELEVAI LABS, INC.
ELEVAI LABS, INC. is a medical aesthetic biotechnology company developing cutting-edge regenerative skin care applications. The company solves the unmet needs in the regenerative aesthetics space through a combination of cutting-edge science and next-generation consumer applications. Elevai Labs develops state-of-the-art topical aesthetic and medical-grade skincare for the physician-dispensed market, with a focus on leveraging stem cell exosome technology. Learn more about Elevai Labs at www.elevaiskincare.com.